Moderna Inc. expects to launch a personalized cancer vaccine that it’s developing with Merck & Co. by 2027, one of its top ...

Half of the patients who received an experimental vaccine for pancreas cancer being developed by Roche and BioNTech following ...

A new study published in the journal Nature emphasizes the promise of a personalized vaccine, autogene cevumeran, in treating ...

A team of Yale researchers recently published promising results from a clinical trial testing the effectiveness of a new ...

The five-year survival rate of people diagnosed with pancreatic cancer is currently 13 percent. Two breakthroughs are ...

The study, published in the Journal of the Royal Society of New Zealand, found that vaccine prevents not only cervical but ...

Forget one-size-fits-all cancer treatments — personalization is the future, and it’s already showing promise. In a groundbreaking early-phase trial, a personalized vaccine triggered a powerful immune ...

Stephen Krahling was a published cancer researcher when vaccine maker Merck brought him on board as a virologist in 1999. That’s when he says he found himself embroiled in an all-hands-on-deck ...

A vaccine to prevent breast cancer is showing good results, and moving into the next stage of clinical trials.

Researchers have developed a cancer vaccine method that can target virtually any solid tumor, amplifying the visibility of ...

President Donald Trump’s pick to lead the National Institutes of Health answered sharp questions in a confirmation hearing ...

Songwriter and music teacher Steve Young of Stevenage, Hertfordshire, made global news as one of the first people to be given ...